NCT/Study#
NCT06325683 /
A072201
RANDOMIZED PHASE II TRIAL OF ANTI-LAG-3 AND ANTI-PD-1 BLOCKADE VS. SOC IN PATIENTS WITH RECURRENT GLIOBLASTOMA
DISEASE GROUP:
Neuro-Oncology
current phase:
Phase II
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information:
